Bortezomib and Filgrastim to Promote Stem Cell Mobilization in Patients With Non-Hodgkin Lymphoma or Multiple Myeloma
Barbara Ann Karmanos Cancer Institute
Barbara Ann Karmanos Cancer Institute
University of Maryland, Baltimore
University of Washington
National Cancer Institute (NCI)
University of California, San Francisco
Northwestern University
Northwestern University